n-hydroxyphthalimide has been researched along with Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| An, T; Kong, L; Li, Y; Liu, J; Wang, M; Xia, C; Yu, C; Zhou, A; Zhou, H | 1 |
1 other study(ies) available for n-hydroxyphthalimide and Neoplasms
| Article | Year |
|---|---|
N-Hydroxyphthalimide exhibits antitumor activity by suppressing mTOR signaling pathway in BT-20 and LoVo cells.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Eukaryotic Initiation Factor-4E; Gene Expression Regulation, Neoplastic; HT29 Cells; Humans; Mitochondria; Neoplasms; Phthalimides; Signal Transduction; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays | 2016 |